ChiCTR2600123044 clinical trial report covering Flunotinib maleate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07542262 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07541430 clinical trial report covering ES-014, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600123039 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543120 clinical trial report covering BW-00163, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07541287 clinical trial report covering JADE-001, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543172 clinical trial report covering Adagrasib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07544784 clinical trial report covering Cadonilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543822 clinical trial report covering Alpelisib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545603 clinical trial report covering Igermetostat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07543640 clinical trial report covering Roflumilast, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07545083 clinical trial report covering Pucotenlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.